ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00250042
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : September 20, 2011
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2005
  Actual Study Completion Date : March 2006